How Helicobacter pylori changed the life of surgeons

Digestive Surgery

Volumn 20, Issue 2, 2003, Pages 93-102

  Kleeff, J ^a   Friess, Helmut ^a   Buchler M W ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gastroduodenal disease; Helicobacter pylori eradication; Surgery

Indexed keywords

BACTERIAL INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENUM ULCER; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER PYLORI; HUMAN; LYMPHOMA; MENETRIER DISEASE; NONHUMAN; PANCREAS CANCER; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH DISEASE; STOMACH HEMORRHAGE; STOMACH MUCOSA; STOMACH OBSTRUCTION; STOMACH PERFORATION; STOMACH SURGERY; SURGEON; TREATMENT INDICATION;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; DUODENAL ULCER; FEMALE; FORECASTING; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MALE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; STOMACH ULCER; SURGICAL PROCEDURES, ELECTIVE;

EID: 0037268826     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069381     Document Type: Review

References (99)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;i:1311-1315.
2. Goodwin CS, Mendall MM, Northfield TC: Helicobacter pylori infection. Lancet 1997;349:265-269.
3. Brown LM: Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 2000;22:283-297.
4. The EUROGAST Study Group: Epidemiology of, and risk factors for, Helicobacter pylori infection among 3,194 asymptomatic subjects in 17 populations. Gut 1993;34:1672-1676.
5. Bode G, Rothenbacher D, Brenner H, Adler G: Helicobacter pylori and abdominal symptoms: A population-based study among preschool children in southern Germany. Pediatrics 1998;101:634-637.
6. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE: Helicobacter pyloriinfection in preschool and school-aged minority children: Effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis 2001;32:1387-1382.
7. Matysiak-Budnik T, Megraud F: Epidemiology of Helicobacter pylori infection with special reference to professional risk. J Physiol Pharmacol 1997;48(suppl 4):3-17.
8. Cremonini F, Gasbarrini A, Armuzzi A, Gasbarrini G: Helicobacter pylori-related diseases. Eur J Clin Invest 2001;31:431-437.
9. Pakodi F, Abdel-Salam OM, Debreceni A, Mozsik G: Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. J Physiol Paris 2000;94:139-152.
10. Graham DY: Therapy of Helicobacter pylori: Current status and issues. Gastroenterology 2000;118(suppl 1):S2-S8.
11. Walker MM, Crabtree JE: Helicobacter pylori infection and the pathogenesis of duodenal ulceration. Ann NY Acad Sci 1998;859:96-111.
12. McGee DJ, Mobley HL: Mechanisms of Helicobacter pylori infection: Bacterial factors. Curr Top Microbiol Immunol 1999;241:155-180.
13. Graham DY, Yamaoka Y: Disease-specific Helicobacter pylori virulence factors: The unfulfilled promise. Helicobacter 2000;5(suppl 1):S3-S9; discussion S27-S31.
14. Ren Z, Pang G, Batey R, Routley D, Russell A, Musicka M, Dunkley M, Beagley K, Clancy R: Non-urease producing Helicobacter pylori in chronic gastritis. Aust NZ J Med 2000;30:578-584.
15. Zheng PY, Hua J, Yeoh KG, Ho B: Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pyloriisolates in an Asian population. Gut 2000;47:18-22.
16. Whitehead R: The classification of chronic gastritis: Current status. J Clin Gastroenterol 1995;21(suppl 1):S131-S134.
17. Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SG: Review article: The development of atrophic gastritis - Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther 1995;9:331-340.
18. Robles-Campos R, Lujan-Mompean JA, Parrilla-Paricio P, Bermejo-Lopez J, Liron-Ruiz R, Torralba-Martinez JA, Morales-Cuenca G, Molina-Martinzez JA: Role of Helicobacter pylori infection and duodenogastric reflux in the pathogenesis of alkaline reflux gastritis after gastric operations. Surg Gynecol Obstet 1993;176:594-598.
19. Rauws EJ, Tytgat GN: Helicobacter pyloriin duodenal and gastric ulcer disease. Baillières Clin Gastroenterol 1995;9:529-547.
20. Walsh JH, Peterson WL: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-991.
21. Roll J, Weng A, Newman J: Diagnosis and treatment of Helicobacter pylori infection among California Medicare patients. Arch Intern Med 1997;157:994-998.
22. Laine L, Hopkins RJ, Girardi LS: Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 1998;93:1409-1415.
23. Bayerdorffer E, Miehlke S, Lehn N, Mannes GA, Hochter W, Weingart J, Klann H, Sommer A, Heldwein W, Hatz R, Simon T, Bolle KH, Bastlein E, Meining A, Ruckdeschel G, Stolte M: Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German Gastric Ulcer Study. Eur J Gastroenterol Hepatol 1996;8:343-349.
24. Malfertheiner P, Megraud F, O'Morain C, Bell D, Bianchi Porro G, Deltenre M, Forman D, Gasbarrini G, Jaup B, Misiewicz JJ, Pajares J, Quina M, Rauws E: Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 1997;9:1-2.
25. Graham DY: Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model. Gastroenterology 1997;113:1983-1991.
26. Misiewicz JJ: Management of Helicobacter pylori-related disorders. Eur J Gastroenterol Hepatol 1997;9(suppl 1):S17-S20; discussion S20-11, S27-19.
27. Gaby AR: Helicobacter pylori eradication: Are there alternatives to antibiotics? Altern Med Rev 2001;6:355-366.
28. Kusters JG: Recent developments in Helicobacter pylori vaccination. Scand J Gastroenterol Suppl 2001;(234):15-21.
29. Hatz R, Schildberg FW: Helicobacter pylori infections - Are these diseases relevant for surgical treatment? Langenbecks Arch Surg 2000;385:75-83.
30. Penn I: The declining role of the surgeon in the treatment of acid-peptic diseases. Arch Surg 1980;115:134-135.
31. Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K: Helicobacter pylori and risk of ulcer bleeding among users of non-steroidal anti-inflammatory drugs: A case-control study. Gastroenterology 1999;116:1305-1309.
32. Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, Lee YT, Chan CS, Li EK, Woo J: Randomised trial of eradication of Helicobacter pyloribefore non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-979.
33. McConnell DB, Baba GC, Deveney CW: Changes in surgical treatment of peptic ulcer disease within a veterans hospital in the 1970s and the 1980s. Arch Surg 1989;124:1164-1167.
34. Janik J, Chwirot P: Peptic ulcer disease before and after introduction of new drugs - A comparison from surgeon's point of view. Med Sci Monit 2000;6:365-368.
35. Graves EJ: Detailed diagnoses and procedures, National Hospital Discharge Survey, 1993. National Center for Health Statistics. Vital Health Stat 13 1995 Oct;(122):1-288.
36. Popovic JR, Kozak LJ: National Hospital Discharge Survey: Annual summary, 1998. National Center for Health Statistics. Vital Health Stat 13 2000 Sept;(148):1-194.
37. Meier R, Wettstein AR: Treatment of acute nonvariceal upper gastrointestinal hemorrhage. Digestion 1999;60:47-52.
38. Neuhaus P, Lemmens HP: Ulcer disease. The role of the surgeon (in German). Ther Umsch 1992;49:776-781.
39. Millat B, Fingerhut A, Borie F: Surgical treatment of complicated duodenal ulcers: Controlled trials. World J Surg 2000;24:299-306.
40. Macri G, Milani S, Surrenti E, Passaleva MT, Salvadori G, Surrenti C: Eradication of Helicobacter pylorireduces the rate of duodenal ulcer rebleeding: A long-term follow-up study. Am J Gastroenterol 1998;93:925-927.
41. Danesh J, Appleby P, Peto R: How often does surgery for peptic ulceration eradicate Helicobacter pylori? Systematic review of 36 studies. BMJ 1998;316:746-747.
42. Boey J, Branicki FJ, Alagaratnam TT, Fok PJ, Choi S, Poon A, Wong J: Proximal gastric vagotomy. The preferred operation for perforations in acute duodenal ulcer. Ann Surg 1988;208:169-174.
43. Jordan PH Jr, Korompai FL: Evolvement of a new treatment for perforated duodenal ulcer. Surg Gynecol Obstet 1976;142:391-395.
44. Svanes C: Trends in perforated peptic ulcer: Incidence, etiology, treatment, and prognosis. World J Surg 2000;24:277-283.
45. Kauffman GL Jr: Duodenal ulcer disease: Treatment by surgery, antibiotics, or both. Adv Surg 2000;34:121-135.
46. Jamieson GG: Current status of indications for surgery in peptic ulcer disease. World J Surg 2000;24:256-258.
47. Alizadeh N, Buhler L, Huber O, Morel P: Conservative treatment of gastroduodenal peptic ulcer perforations: Indications and results (in German). Schweiz Med Wochenschr Suppl 1997;89:17S-19S.
48. Pescatore P, Halkic N, Calmes JM, Blum A, Gillet M: Combined laparoscopic-endoscopic method using an omental plug for therapy of gastroduodenal ulcer perforation. Gastrointest Endosc 1998;48:411-414.
49. Kate V, Ananthakrishnan N, Badrinath S: Effect ofHelicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: Retrospective and prospective randomized controlled studies. Br J Surg 2001;88:1054-1058.
50. 2-receptor blockers and proton pump inhibitors. Scand J Gastroenterol 1997;32:523-529.
51. Lam Y, Lau JY, Law KB, Sung JJ, Chung SS: Endoscopic balloon dilation and Helicobacter pylori eradication in the treatment of gastric outlet obstruction. Gastrointest Endosc 1997;46:379-380.
52. Choudhary AM, Roberts I, Nagar A, Tabrez S, Gupta T: Helicobacter pylori-related gastric outlet obstruction: Is there a role for medical treatment? J Clin Gastroenterol 2001;32:272-273.
53. Taskin V, Gurer I, Ozyilkan E, Sare M, Hilmioglu F: Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction. Helicobacter 2000;5:38-40.
54. al-Assi MT, Graham DY: Peptic ulcer disease, Helicobacter pylori, and the surgeon: Changing of the guard. Curr Opin Gen Surg 1994;120-124.
55. Sanchez-Bueno F, Marin P, Rios A, Aguayo JL, Robles R, Pinero A, Fernandez JA, Parrilla P: Has the incidence of perforated peptic ulcer decreased over the last decade? With Invited Commentary. Dig Surg 2001;18:444-448.
56. Henriksson AE, Edman AC, Nilsson I, Bergqvist D, Wadstrom T: Helicobacter pyloriand the relation to other risk factors in patients with acute bleeding peptic ulcer. Scand J Gastroenterol 1998;33:1030-1033.
57. Gisbert JP, Gonzalez L, de Pedro A, Valbuena M, Prieto B, Llorca I, Briz R, Khorrami S, Garcia-Gravalos R, Pajares JM: Helicobacter pyloriand bleeding duodenal ulcer: Prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 2001;36:717-724.
58. Friess H, Malfertheiner P, Flock F, Baczako K, Stanescu A, Büchler MW: Elimination of Helicobacter pylori by single shot antibiotic treatment in patients undergoing proximal vagotomy. Eur J Gastroenterol Hepatol 1992;4:719-725.
59. Schilling D, Adamek HE, Wilke J, Schauwecker P, Martin WR, Arnold JC, Benz C, Labenz J, Riemann JF: Prevalence and clinical importance of Helicobacter pyloriinfection in patients after partial gastric resection for peptic ulcer disease. A prospective evaluation of Helicobacter pylori infection on 50 resected patients compared with matched nonresected controls. Z Gastroenterol 1999;37:127-132.
60. Lee YT, Sung JJ, Choi CL, Chan FK, Ng EK, Ching JY, Leung WK, Chung SC: Ulcer recurrence after gastric surgery: Is Helicobacter pylori the culprit? Am J Gastroenterol 1998;93:928-931.
61. Eid R, Moss SF: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2002;346:65-67.
62. Zullo A, Hassan C, Morini S: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2002;346:65-67.
63. Blaser MJ, Berg DE: Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001;107:767-773.
64. Meining A, Bayerdorffer E, Muller P, Miehlke S, Lehn N, Holzel D, Hatz R, Stolte M: Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch 1998;432:311-314.
65. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
66. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y: Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1995;75:2789-2793.
67. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404: 398-402.
68. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-353.
69. Hatz RA, Lehn N, Leyh S, Kaps MF, Bayerdorffer E, Stolte M, Schildberg FW: Prevalence of Helicobacter pylori infection in stomach carcinoma (in German). Chirurg 1996;67:403-408.
70. Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID, Perez-Perez GI: Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer 1993;55:799-802.
71. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M: Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998;115:642-648.
72. Pounder RE, Williams MP: The treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11(suppl 1):35-41.
73. Maconi G, Kurihara H, Taschieri AM, Bianchi Porro G: Management of Helicobacter pylori infection: Gastroenterological and surgical perspectives. J Chemother 1999;11:581-590.
74. Fendrick AM: The role of economic evaluation in the diagnosis and treatment of Helicobacter pylori infection. Gastroenterol Clin North Am 2000;29:837-851.
75. Garcia-Altes A, Jovell AJ, Serra-Prat M, Aymerich M: Management of Helicobacter pylori in duodenal ulcer: A cost-effectiveness analysis. Aliment Pharmacol Ther 2000;14:1631-1638.
76. Wotherspoon AC: A Critical Review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma. Curr Gastroenterol Rep 2000;2:494-498.
77. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.
78. Caspary WF, Arnold R, Bayerdorffer E, Behrens R, Birkner B, Braden B, Domschke W, Labenz J, Koletzko S, Malfertheiner P, Menge H, Rosch W, Schepp W, Strauch M, Stolte M: Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases (in German). Z Gastroenterol 1996;34:392-401.
79. Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wundisch T, Ehninger G, Stolte M, Bayerdorffer E: Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-1355.
80. Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C: Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 2001;86:609-617.
81. Bayerdorffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M: Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori - Is Helicobacter pylori a pathogenic factor in Ménétrier's disease? Gut 1994;35:701-704.
82. Simon L, Feher I, Salamon A, Vadasz E: Reversible protein-losing hypertrophic gastropathy: Causal relationship with Helicobacter pylori infection, or simple coincidence? Am J Gastroenterol 2000;95:1091-1092.
83. Kaneko T, Akamatsu T, Gotoh A, Shimodaira K, Shimizu T, Kiyosawa K, Katsuyama T, Momose A: Remission of Ménétrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol 1999;94:272-273.
84. Scharschmidt BF: The natural history of hypertrophic gastrophy (Ménétrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med 1977;63:644-652.
85. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-1022.
86. Meining A, Kiel G, Stolte M: Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. Aliment Pharmacol Ther 1998;12:735-740.
87. Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB, Nelis F, Snel P, Luckers A, Dekkers CP, Havu N, Meuwissen SG: Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety. Ann Intern Med 1994;121:161-167.
88. Graham DY, Yamaoka Y: H. pylori and cagA: Relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998;3:145-151.
89. Blaser MJ: Hypothesis: The changing relationships of Helicobacter pylori and humans: Implications for health and disease. J Infect Dis 1999;179:1523-1530.
90. Warburton-Timms VJ, Charlett A, Valori RM, Uff JS, Shepherd NA, Barr H, McNulty CA: The significance of cagA(+) Helicobacter pylori in reflux oesophagitis. Gut 2001;49:341-346.
91. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M: Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: Analysis of 5,732 Japanese subjects. Gut 2001;49:335-340.
92. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Toyota T, Shimosegawa T: Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 2001;49:330-334.
93. Falk GW: The possible role of Helicobacter pylori in GERD. Semin Gastrointest Dis 2001;12:186-195.
94. Falk GW: GERD and H. pylori: Is there a link? Semin Gastrointest Dis 2001;12:16-25.
95. Anand BS, Graham DY: Ulcer and gastritis. Endoscopy 1999;31:215-225.
96. Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G, Fried M: Helicobacter pyloriand symptomatic relapse of gastro-oesophageal reflux disease: A randomised controlled trial. Lancet 2001;357:1738-1742.
97. Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT: Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 2001;121:1120-1126.
98. Koop H: Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy 2002;34:97-103.
99. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, Virtamo J, Albanes D: Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001;93:937-941.